Solid ovarian tumours in childhood: a 35-year review in a single institution.
OBJECTIVE
Solid ovarian tumours are uncommon in childhood. Our aim is to evaluate the outcomes in a single institution over 35 years.


METHODS
We reviewed their clinical presentation, management, pathology and outcomes from 1972 to 2007.


RESULTS
Fifty-three patients, with a median age of 9.2 years (range 0.9-14.2), were registered. Common symptoms at presentation were abdominal pain (75.8%) and abdominal mass (57.4%). Histopathological diagnoses were: 26 mature teratoma, 10 immature teratoma, 8 dysgerminoma, 5 granulosa cell tumours, 2 yolk sac tumours, 1 gonadoblastoma and 1 embryonal carcinoma. Staging (FIGO) for malignant/borderline tumours was: 17 stage I, 1 stage II, 8 stage III and 1 stage IV. Unilateral salpingo-oophorectomy was performed in 47 cases. Sixteen patients underwent chemotherapy after surgery (15 with platinum-based regimen) and postoperative radiotherapy was given in 5 cases. Recurrence was observed in 2 patients and one died (stage III immature teratoma) after a second relapse despite multiple chemotherapy, surgery and radiotherapy. Five-year OS and 5-year EFS were 97% and 94% respectively.


CONCLUSIONS
Although rare, ovarian tumours must be included in the differential diagnosis of abdominal pain in childhood. Our results confirm their excellent prognosis using conservative surgery and platinum-based chemotherapy. The key point is to maintain excellent outcome while reducing associated morbidity and preserving fertility.
Andrés
M M
MM
Paediatric Oncology Unit, Hospital Universitario Infantil La Fe, Valencia, Spain. maradres@hotmail.com
Costa
E
E
Cañete
A
A
Moreno
L
L
Castel
V
V
D000293:Adolescent; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007223:Infant; D053208:Kaplan-Meier Estimate; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000401:mortality* / Q000628:therapy*; D010052:Ovariectomy; D011878:Radiotherapy; D016896:Treatment Outcome
D000970:Antineoplastic Agents
Lancet Oncol. 2005 Apr;6(4):209-18
15811616
J Pediatr Hematol Oncol. 2000 Sep-Oct;22(5):422-7
11037853
J Clin Oncol. 2004 Sep 1;22(17):3563-9
15337806
Pediatr Blood Cancer. 2009 Mar;52(3):398-401
19023889
Cancer. 1976 May;37(5):2359-72
1260722
Cir Pediatr. 1997 Jul;10(3):104-7
9376232
Surg Oncol. 2007 Nov;16(3):205-13
17719771
J Clin Oncol. 1999 Jul;17(7):2137-43
10561269
J Pediatr Surg. 2001 May;36(5):693-9
11329568
Cir Pediatr. 2007 Jan;20(1):15-8
17489487
J Clin Oncol. 2000 Nov 15;18(22):3809-18
11078494
J Clin Oncol. 1997 Feb;15(2):620-4
9053485
Am J Obstet Gynecol. 1994 Jun;170(6):1780-6; discussion 1786-9
8203439
Med Pediatr Oncol. 1998 Apr;30(4):217-27
9473756
J Pediatr Surg. 2004 Mar;39(3):424-9; discussion 424-9
15017564
J Clin Oncol. 2004 Jul 1;22(13):2691-700
15226336
Pediatr Blood Cancer. 2006 Apr;46(4):459-64
16206211
Eur J Cancer. 2000 Feb;36(3):376-83
10708940
J Pediatr Surg. 1993 Jul;28(7):930-3
8229571
Obstet Gynecol. 1988 Jun;71(6 Pt 1):858-60
3368170